{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:18Z","timestamp":1792791438532,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20229ZA2YF"],"award-info":[{"award-number":["20229ZA2YF"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022NH9MXB"],"award-info":[{"award-number":["2022NH9MXB"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.smim.2026.102034","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T19:09:26Z","timestamp":1779476966000},"page":"102034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The multifaceted role of B lymphocytes in type 1 diabetes"],"prefix":"10.1016","volume":"82","author":[{"given":"Salma Ayman","family":"Khalefa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moufida","family":"Ben Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Usuelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetham","family":"Yerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Lunati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fiorina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.smim.2026.102034_bib1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.4049\/jimmunol.1202104","article-title":"Tolerant anti-insulin B cells are effective APCs","volume":"190","author":"Kendall","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.imlet.2014.01.010","article-title":"B cells and type 1 diabetes \u2026in mice and men","volume":"160","author":"Hinman","year":"2014","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.smim.2026.102034_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115425","article-title":"Activated polyreactive B cells are clonally expanded in autoantibody positive and patients with recent-onset type 1 diabetes","volume":"44","author":"Nicholas","year":"2025","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.smim.2026.102034_bib4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2337\/diab.46.6.941","article-title":"B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice","volume":"46","author":"Noorchashm","year":"1997","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.smim.2026.102034_bib5","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2337\/db08-0420","article-title":"Targeting CD22 reprograms B-cells and reverses autoimmune diabetes","volume":"57","author":"Fiorina","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI83840","article-title":"Rituximab does not reset defective early B cell tolerance checkpoints","volume":"126","author":"Chamberlain","year":"2016","journal-title":"J. Clin. Invest"},{"issue":"9","key":"10.1016\/j.smim.2026.102034_bib7","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1172\/JCI45790","article-title":"The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans","volume":"121","author":"Menard","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"14","key":"10.1016\/j.smim.2026.102034_bib8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJMoa010465","article-title":"Development of type 1 diabetes despite severe hereditary B-cell deficiency","volume":"345","author":"Martin","year":"2001","journal-title":"N. Engl. J. Med"},{"issue":"22","key":"10.1016\/j.smim.2026.102034_bib9","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/dc13-0626","article-title":"B-lymphocyte depletion with rituximab and beta-cell function: two-year results","volume":"37","author":"Pescovitz","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.smim.2026.102034_bib11","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1084\/jem.184.5.2049","article-title":"B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new \"speed congenic\" stock of NOD.Ig mu null mice","volume":"184","author":"Serreze","year":"1996","journal-title":"J. Exp. Med"},{"issue":"12","key":"10.1016\/j.smim.2026.102034_bib12","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1172\/JCI32405","article-title":"Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice","volume":"117","author":"Hu","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.smim.2026.102034_bib13","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.4049\/jimmunol.181.11.8133","article-title":"vivo BLyS\/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice","volume":"181","author":"Zekavat","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102034_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-59745-395-0_17","article-title":"Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse","volume":"380","author":"Giarratana","year":"2007","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.smim.2026.102034_bib15","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1073\/pnas.84.8.2435","article-title":"The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique","volume":"84","author":"Acha-Orbea","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.smim.2026.102034_bib16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diab.47.8.1177","article-title":"Molecular basis for HLA-DQ associations with IDDM","volume":"47","author":"Nepom","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.smim.2026.102034_bib17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clim.2017.09.021","article-title":"Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes","volume":"183","author":"Hanley","year":"2017","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s10020-022-00447-y","article-title":"Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes","volume":"28","author":"Ling","year":"2022","journal-title":"Mol. Med"},{"issue":"4","key":"10.1016\/j.smim.2026.102034_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125556","article-title":"Cell type-specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes","volume":"4","author":"Dufort","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.smim.2026.102034_bib20","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.2337\/diabetes.53.10.2581","article-title":"Investigation of the role of B-cells in type 1 diabetes in the NOD mouse","volume":"53","author":"Wong","year":"2004","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.smim.2026.102034_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2337\/db17-0937","article-title":"Loss of B-cell anergy in type 1 diabetes is associated with high-risk HLA and non-HLA disease susceptibility alleles","volume":"67","author":"Smith","year":"2018","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf7153","article-title":"PTPN22 inhibition resets defective human central B cell tolerance","volume":"1","author":"Schickel","year":"2016","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.4049\/jimmunol.167.2.1081","article-title":"Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice","volume":"167","author":"Tian","year":"2001","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2026.102034_bib24","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.4049\/jimmunol.179.11.7225","article-title":"Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner","volume":"179","author":"Hussain","year":"2007","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102034_bib25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4049\/jimmunol.2001127","article-title":"Regulatory B cells in autoimmune diabetes","volume":"206","author":"Ben Nasr","year":"2021","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2026.102034_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrneph.2017.138","article-title":"B cells in type 1 diabetes mellitus and diabetic kidney disease","volume":"13","author":"Smith","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.immuni.2007.12.004","article-title":"Sites and stages of autoreactive B cell activation and regulation","volume":"28","author":"Shlomchik","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20011453","article-title":"Autoreactive B cells in the marginal zone that express dual receptors","volume":"195","author":"Li","year":"2002","journal-title":"J. Exp. Med"},{"issue":"5","key":"10.1016\/j.smim.2026.102034_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nri799","article-title":"Marginal-zone B cells","volume":"2","author":"Martin","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2026.102034_bib30","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.4049\/jimmunol.166.4.2412","article-title":"Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds","volume":"166","author":"Qian","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2026.102034_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1084\/jem.190.5.639","article-title":"Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice","volume":"190","author":"Wang","year":"1999","journal-title":"J. Exp. Med"},{"issue":"12","key":"10.1016\/j.smim.2026.102034_bib32","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00125-018-4730-z","article-title":"Silencing of high-affinity insulin-reactive B lymphocytes by anergy and impact of the NOD genetic background in mice","volume":"61","author":"Smith","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.smim.2026.102034_bib33","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","article-title":"Differential insulitic profiles determine the extent of beta-cell destruction and the age at onset of type 1 diabetes","volume":"65","author":"Leete","year":"2016","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.smim.2026.102034_bib34","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2337\/db13-1798","article-title":"Loss of anergic B cells in prediabetic and new-onset type 1 diabetic patients","volume":"64","author":"Smith","year":"2015","journal-title":"Diabetes"},{"issue":"20","key":"10.1016\/j.smim.2026.102034_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88242","article-title":"Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes","volume":"1","author":"Seay","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.smim.2026.102034_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2017.09.012","article-title":"Risk of beta-cell autoimmunity presence for progression to type 1 diabetes: A systematic review and meta-analysis","volume":"86","author":"Ling","year":"2018","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.smim.2026.102034_bib37","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2337\/dc14-1575","article-title":"Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual beta-cell function in recent-onset type 1 diabetes","volume":"38","author":"Demeester","year":"2015","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.smim.2026.102034_bib38","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00125-017-4284-5","article-title":"The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes","volume":"60","author":"Bloem","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.smim.2026.102034_bib39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nm0402-399","article-title":"Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice","volume":"8","author":"Greeley","year":"2002","journal-title":"Nat. Med"},{"issue":"7","key":"10.1016\/j.smim.2026.102034_bib40","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/diabetes.54.7.2026","article-title":"Maternal factors in a model of type 1 diabetes differentially affect the development of insulitis and overt diabetes in offspring","volume":"54","author":"Kagohashi","year":"2005","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.smim.2026.102034_bib41","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.161.8.3912","article-title":"B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice","volume":"161","author":"Serreze","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102034_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2015.07.014","article-title":"Immunogenetics of type 1 diabetes: a comprehensive review","volume":"64","author":"Noble","year":"2015","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.smim.2026.102034_bib43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1006\/jaut.1994.1049","article-title":"Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice","volume":"7","author":"De Aizpurua","year":"1994","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2007.11.005","article-title":"Insulin as an autoantigen in NOD\/human diabetes","volume":"20","author":"Zhang","year":"2008","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102034_bib45","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s00125-020-05114-7","article-title":"Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8(+) T cells and exhibit a distinct CD95(hi) B cell phenotype","volume":"63","author":"Hanna","year":"2020","journal-title":"Diabetologia"},{"issue":"5638","key":"10.1016\/j.smim.2026.102034_bib46","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/cei\/uxad136","article-title":"Shift in the B cell subsets between children with type 1 diabetes and\/or celiac disease","volume":"216","author":"Tompa","year":"2024","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.53.1.1","article-title":"Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes","volume":"53","author":"Koczwara","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib49","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4049\/jimmunol.163.2.743","article-title":"I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice","volume":"163","author":"Noorchashm","year":"1999","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2337\/db07-0589","article-title":"Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells","volume":"57","author":"Marino","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.smim.2026.102034_bib51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/db07-1256","article-title":"B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes","volume":"57","author":"Brodie","year":"2008","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.smim.2026.102034_bib52","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1002\/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E","article-title":"The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors","volume":"32","author":"Silveira","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.smim.2026.102034_bib53","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.4049\/jimmunol.167.10.5535","article-title":"B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice","volume":"167","author":"Hulbert","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102034_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-065X.1998.tb01223.x","article-title":"Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes","volume":"164","author":"Mamula","year":"1998","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.smim.2026.102034_bib55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.coi.2010.10.002","article-title":"To B or not to B--pathogenic and regulatory B cells in autoimmune diabetes","volume":"22","author":"Wong","year":"2010","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4049\/jimmunol.169.2.665","article-title":"Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope","volume":"169","author":"Jaume","year":"2002","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib57","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaut.2009.04.002","article-title":"Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes","volume":"33","author":"Weenink","year":"2009","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.smim.2026.102034_bib58","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1084\/jem.20180300","article-title":"Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity","volume":"215","author":"Ito","year":"2018","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.smim.2026.102034_bib59","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.4049\/jimmunol.167.8.4351","article-title":"Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice","volume":"167","author":"Greeley","year":"2001","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2026.102034_bib60","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db07-1331","article-title":"HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families","volume":"57","author":"Erlich","year":"2008","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.smim.2026.102034_bib61","doi-asserted-by":"crossref","DOI":"10.4161\/19382014.2014.950547","article-title":"The impact of anti-inflammatory cytokines on the pancreatic beta-cell","volume":"6","author":"Russell","year":"2014","journal-title":"Islets"},{"issue":"11","key":"10.1016\/j.smim.2026.102034_bib62","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2337\/db12-0006","article-title":"B-cell cross-presentation of autologous antigen precipitates diabetes","volume":"61","author":"Marino","year":"2012","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib63","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.174.2.680","article-title":"Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis","volume":"174","author":"Hussain","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","article-title":"Analysis of islet inflammation in human type 1 diabetes","volume":"155","author":"Willcox","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.smim.2026.102034_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.phrs.2014.07.004","article-title":"The rise, fall, and resurgence of immunotherapy in type 1 diabetes","volume":"98","author":"Ben Nasr","year":"2015","journal-title":"Pharm. Res"},{"issue":"5","key":"10.1016\/j.smim.2026.102034_bib66","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.4049\/jimmunol.180.5.2863","article-title":"B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions","volume":"180","author":"Xiu","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102034_bib67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.it.2011.03.006","article-title":"B cell-directed therapies in type 1 diabetes","volume":"32","author":"Marino","year":"2011","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.smim.2026.102034_bib68","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2026.102034_bib69","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.smim.2026.102034_bib70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10-producing B cells","volume":"197","author":"Mauri","year":"2003","journal-title":"J. Exp. Med"},{"issue":"6","key":"10.1016\/j.smim.2026.102034_bib71","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","article-title":"Jr.: Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice","volume":"184","author":"Wolf","year":"1996","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ajt.15546","article-title":"Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs","volume":"20","author":"Mohib","year":"2020","journal-title":"Am. J. Transpl."},{"issue":"10","key":"10.1016\/j.smim.2026.102034_bib73","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/eji.201040673","article-title":"IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro","volume":"40","author":"Bouaziz","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib74","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"173","key":"10.1016\/j.smim.2026.102034_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.smim.2026.102034_bib76","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8935694","article-title":"Altered regulatory B cell subsets in children with type 1 diabetes mellitus","volume":"2020","author":"El-Mokhtar","year":"2020","journal-title":"J. Immunol. Res"},{"issue":"1-2","key":"10.1016\/j.smim.2026.102034_bib77","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2011.08.019","article-title":"Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive\/memory Breg ratio during a relapse but not in remission","volume":"239","author":"Knippenberg","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.smim.2026.102034_bib78","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1177\/0300060518783083","article-title":"Reduced peripheral blood regulatory B cell levels are not associated with the expanded disability status scale score in multiple sclerosis","volume":"46","author":"Guo","year":"2018","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.smim.2026.102034_bib79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cei.13408","article-title":"Decrease in the proportion of CD24(hi) CD38(hi) B cells and impairment of their regulatory capacity in type 1 diabetes patients","volume":"200","author":"Wang","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.smim.2026.102034_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.773896","article-title":"Altered Tim-1 and IL-10 expression in regulatory B cell subsets in type 1 diabetes","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2026.102034_bib81","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4049\/jimmunol.1900488","article-title":"CD24(hi)CD38(hi) and CD24(hi)CD27(+) human regulatory b cells display common and distinct functional characteristics","volume":"203","author":"Hasan","year":"2019","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2026.102034_bib82","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc16-2121","article-title":"Increased interleukin-35 levels in patients with type 1 diabetes with remaining C-peptide","volume":"40","author":"Espes","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.smim.2026.102034_bib83","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2015.02.004","article-title":"B-Cells induce regulatory T cells through TGF-beta\/IDO production in A CTLA-4 dependent manner","volume":"59","author":"Nouel","year":"2015","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.smim.2026.102034_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070131","article-title":"Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10","volume":"8","author":"Klinker","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.smim.2026.102034_bib85","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/ncomms6997","article-title":"PD-L1hi B cells are critical regulators of humoral immunity","volume":"6","author":"Khan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102034_bib86","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fimmu.2017.00402","article-title":"Expansion of fasl-expressing CD5(+) B cells in type 1 diabetes patients","volume":"8","author":"Saxena","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:05Z","timestamp":1792787885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532326000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":86,"alternative-id":["S1044532326000217"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2026.102034","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifaceted role of B lymphocytes in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2026.102034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102034"}}